Evonik acquires biomaterials portfolio from Alabama firm
In Alabama, German specialty chemicals company Evonik has acquired a line of biomaterials from Birmingham’s DURECT Corporation for $15 million. The LACTEL Absorbable Polymers portfolio is comprised of biodegradable, PLGA-based polymers used in drug delivery, tissue engineering, and 3D printing of implantable medical devices. The business will be integrated into Evonik’s Health Care business. “The […]














